Questions Over Avandia Safety Continue

Controversy continues to plague GlaxoSmithKline's diabetes drug Avandia. Several studies have found that Avandia raises heart risks in diabetics, and the U.S. Food and Drug Administration is weighing whether the drug is too dangerous to stay on the market. But in a new study of more than 29,000 diabetics, done by researchers at health insurer [...]